Short-term Increase in Risk of Overweight and Concomitant Systolic Blood Pressure Elevation in Treatment-Naïve Persons Starting INSTI-Based Antiretroviral Therapy.

In the multivariate model controlling for age, sex, baseline body weight, CD4 count, plasma viral load, TDF backbone, and HIV transmission category, adjusted average weight gain at 96 weeks was greater with INSTI-based regimens, although that difference did not reach statistical significance.

also in 111,027 other papers